These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25566919)

  • 1. Lack of effectiveness of keratin dressings in epidermolysis bullosa.
    Sürücü HA; Yesilova Y; Turan E; Aksoy M; Tanrikulu O; Eroglu N
    Indian J Dermatol Venereol Leprol; 2015; 81(1):91-2. PubMed ID: 25566919
    [No Abstract]   [Full Text] [Related]  

  • 2. Keratin gel in the management of Epidermolysis bullosa.
    Denyer J; Marsh C; Kirsner RS
    J Wound Care; 2015 Oct; 24(10):446-50. PubMed ID: 26488735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.
    Chelliah MP; Zinn Z; Khuu P; Teng JMC
    Pediatr Dermatol; 2018 Jul; 35(4):e224-e227. PubMed ID: 29786144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of collagenase inhibition on bullous eruption and healing process in epidermolysis bullosa].
    Coradello H; Lubec G
    Hautarzt; 1979 Feb; 30(2):89-91. PubMed ID: 217851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa.
    Than MP; Smith RA; Cassidy S; Kelly R; Marsh C; Maderal A; Kirsner RS
    J Dermatolog Treat; 2013 Aug; 24(4):290-1. PubMed ID: 22208480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpetic infection in epidermolysis bullosa.
    Rubin AI; Garzon MC; Morel KD
    Pediatr Dermatol; 2006; 23(4):355-7. PubMed ID: 16918632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a treatment for epidermolysis bullosa.
    Haber RM; Ramsay CA; Boxall LB
    Can Med Assoc J; 1984 Jul; 131(1):10-11, 14. PubMed ID: 6733642
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effectiveness of phenytoin in the treatment of epidermolysis bullosa hereditaria dystrophica partim inversa (Gedde-Dahl)].
    Bandmann HJ; Perwein E
    Z Hautkr; 1982 Nov; 57(21):1587-98. PubMed ID: 7148073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wound healing and epidermolysis bullosa.
    Carter DM; Lin AN
    Arch Dermatol; 1988 May; 124(5):732-3. PubMed ID: 3129995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin therapy for junctional epidermolysis bullosa.
    Rogers RB; Yancey KB; Allen BS; Guill MF
    Arch Dermatol; 1983 Nov; 119(11):925-6. PubMed ID: 6639114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E treatment of epidermolysis bullosa. Changes in tissue collagenase levels.
    Michaelson JD; Schmidt JD; Dresden MH; Duncan WC
    Arch Dermatol; 1974 Jan; 109(1):67-9. PubMed ID: 4358395
    [No Abstract]   [Full Text] [Related]  

  • 14. Wound management for children with epidermolysis bullosa.
    Denyer JE
    Dermatol Clin; 2010 Apr; 28(2):257-64, viii-ix. PubMed ID: 20447488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common wound colonizers in patients with epidermolysis bullosa.
    Brandling-Bennett HA; Morel KD
    Pediatr Dermatol; 2010; 27(1):25-8. PubMed ID: 20199405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omiderm: a synthetic cover for exposed areas in epidermolysis bullosa.
    Sagi A; Stahl N; Hauben D
    Ann Plast Surg; 1988 Feb; 20(2):133-5. PubMed ID: 3355058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital bullous epidermolysis and protease inhibitors. The point of view of laboratory].
    Buneaux JJ
    Ann Pediatr (Paris); 1978 Feb; 25(2):143-4; author reply 144. PubMed ID: 16114318
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of epidermolysis bullosa in children. Effective topical steroid treatment.
    Severin GL; Farber EM
    Arch Dermatol; 1967 Mar; 95(3):302-9. PubMed ID: 6019801
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidermolysis bullosa. Assessment of a treatment regimen.
    Haber RM; Ramsay CA; Boxall LB
    Int J Dermatol; 1985 Jun; 24(5):324-8. PubMed ID: 4018985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolysis bullosa--new therapeutic approaches.
    Eisenberg M; Stevens LH; Schofield PJ
    Australas J Dermatol; 1978 Apr; 19(1):1-8. PubMed ID: 210757
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.